The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Breast Biopsy Solution Market Research Report 2025
Synopsis
Breast biopsy solutions refer to the various methods and techniques used to obtain tissue samples from the breast for diagnostic purposes. A breast biopsy is typically performed when there is a suspicious lump, mass, or abnormality detected during a breast examination, mammogram, or ultrasound. The biopsy allows healthcare professionals to analyze the tissue sample and determine whether the breast abnormality is benign (non-cancerous) or malignant (cancerous).
Global Breast Biopsy Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Breast Biopsy Solution market research.
The global breast biopsy solution market has experienced steady growth over the years, driven by several factors, including an increasing incidence of breast cancer, growing awareness about early detection and screening programs, and advancements in medical imaging technologies. Breast biopsy solutions play a crucial role in the accurate diagnosis of breast abnormalities and are essential in guiding appropriate treatment plans for patients. The breast biopsy solution market has a significant presence in North America, Europe, and Asia-Pacific, with these regions accounting for a substantial share of the global market. Increasing awareness about breast cancer and improved healthcare infrastructure are some of the key factors driving market growth in these regions. The breast biopsy solution market is expected to continue its growth trajectory in the coming years, driven by factors such as the aging population, increasing incidence of breast cancer, technological advancements, and government initiatives to improve breast cancer screening and diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Breast Biopsy Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mammotome
Hologic
BD
Qiagen
Illumina
GE Healthcare
Siemens Healthineers
Trivitron Healthcare
Stryker
Merit Medical Systems
IZI Medical
INRAD
Argon Medical
Beekley Medical
Segment by Type
Fine Needle Aspiration (FNA) Biopsy
Core Needle Biopsy
Open (Surgical) Biopsy
Segment by Application
Early Cancer Screening
Treatment Monitoring
Recurrence Monitoring
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Breast Biopsy Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Breast biopsy solutions refer to the various methods and techniques used to obtain tissue samples from the breast for diagnostic purposes. A breast biopsy is typically performed when there is a suspicious lump, mass, or abnormality detected during a breast examination, mammogram, or ultrasound. The biopsy allows healthcare professionals to analyze the tissue sample and determine whether the breast abnormality is benign (non-cancerous) or malignant (cancerous).
Global Breast Biopsy Solution market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Breast Biopsy Solution market research.
The global breast biopsy solution market has experienced steady growth over the years, driven by several factors, including an increasing incidence of breast cancer, growing awareness about early detection and screening programs, and advancements in medical imaging technologies. Breast biopsy solutions play a crucial role in the accurate diagnosis of breast abnormalities and are essential in guiding appropriate treatment plans for patients. The breast biopsy solution market has a significant presence in North America, Europe, and Asia-Pacific, with these regions accounting for a substantial share of the global market. Increasing awareness about breast cancer and improved healthcare infrastructure are some of the key factors driving market growth in these regions. The breast biopsy solution market is expected to continue its growth trajectory in the coming years, driven by factors such as the aging population, increasing incidence of breast cancer, technological advancements, and government initiatives to improve breast cancer screening and diagnosis.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Breast Biopsy Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Mammotome
Hologic
BD
Qiagen
Illumina
GE Healthcare
Siemens Healthineers
Trivitron Healthcare
Stryker
Merit Medical Systems
IZI Medical
INRAD
Argon Medical
Beekley Medical
Segment by Type
Fine Needle Aspiration (FNA) Biopsy
Core Needle Biopsy
Open (Surgical) Biopsy
Segment by Application
Early Cancer Screening
Treatment Monitoring
Recurrence Monitoring
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Breast Biopsy Solution report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
Index1 Breast Biopsy Solution Market Overview
1.1 Product Overview and Scope of Breast Biopsy Solution
1.2 Breast Biopsy Solution Segment by Type
1.2.1 Global Breast Biopsy Solution Market Value Comparison by Type (2023-2029)
1.2.2 Fine Needle Aspiration (FNA) Biopsy
1.2.3 Core Needle Biopsy
1.2.4 Open (Surgical) Biopsy
1.3 Breast Biopsy Solution Segment by Application
1.3.1 Global Breast Biopsy Solution Market Value by Application: (2023-2029)
1.3.2 Early Cancer Screening
1.3.3 Treatment Monitoring
1.3.4 Recurrence Monitoring
1.3.5 Others
1.4 Global Breast Biopsy Solution Market Size Estimates and Forecasts
1.4.1 Global Breast Biopsy Solution Revenue 2018-2029
1.4.2 Global Breast Biopsy Solution Sales 2018-2029
1.4.3 Global Breast Biopsy Solution Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 Breast Biopsy Solution Market Competition by Manufacturers
2.1 Global Breast Biopsy Solution Sales Market Share by Manufacturers (2018-2023)
2.2 Global Breast Biopsy Solution Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Breast Biopsy Solution Average Price by Manufacturers (2018-2023)
2.4 Global Breast Biopsy Solution Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Breast Biopsy Solution, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Breast Biopsy Solution, Product Type & Application
2.7 Breast Biopsy Solution Market Competitive Situation and Trends
2.7.1 Breast Biopsy Solution Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Breast Biopsy Solution Players Market Share by Revenue
2.7.3 Global Breast Biopsy Solution Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Breast Biopsy Solution Retrospective Market Scenario by Region
3.1 Global Breast Biopsy Solution Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Breast Biopsy Solution Global Breast Biopsy Solution Sales by Region: 2018-2029
3.2.1 Global Breast Biopsy Solution Sales by Region: 2018-2023
3.2.2 Global Breast Biopsy Solution Sales by Region: 2024-2029
3.3 Global Breast Biopsy Solution Global Breast Biopsy Solution Revenue by Region: 2018-2029
3.3.1 Global Breast Biopsy Solution Revenue by Region: 2018-2023
3.3.2 Global Breast Biopsy Solution Revenue by Region: 2024-2029
3.4 North America Breast Biopsy Solution Market Facts & Figures by Country
3.4.1 North America Breast Biopsy Solution Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Breast Biopsy Solution Sales by Country (2018-2029)
3.4.3 North America Breast Biopsy Solution Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Breast Biopsy Solution Market Facts & Figures by Country
3.5.1 Europe Breast Biopsy Solution Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Breast Biopsy Solution Sales by Country (2018-2029)
3.5.3 Europe Breast Biopsy Solution Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Breast Biopsy Solution Market Facts & Figures by Country
3.6.1 Asia Pacific Breast Biopsy Solution Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Breast Biopsy Solution Sales by Country (2018-2029)
3.6.3 Asia Pacific Breast Biopsy Solution Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Breast Biopsy Solution Market Facts & Figures by Country
3.7.1 Latin America Breast Biopsy Solution Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Breast Biopsy Solution Sales by Country (2018-2029)
3.7.3 Latin America Breast Biopsy Solution Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Breast Biopsy Solution Market Facts & Figures by Country
3.8.1 Middle East and Africa Breast Biopsy Solution Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Breast Biopsy Solution Sales by Country (2018-2029)
3.8.3 Middle East and Africa Breast Biopsy Solution Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Breast Biopsy Solution Sales by Type (2018-2029)
4.1.1 Global Breast Biopsy Solution Sales by Type (2018-2023)
4.1.2 Global Breast Biopsy Solution Sales by Type (2024-2029)
4.1.3 Global Breast Biopsy Solution Sales Market Share by Type (2018-2029)
4.2 Global Breast Biopsy Solution Revenue by Type (2018-2029)
4.2.1 Global Breast Biopsy Solution Revenue by Type (2018-2023)
4.2.2 Global Breast Biopsy Solution Revenue by Type (2024-2029)
4.2.3 Global Breast Biopsy Solution Revenue Market Share by Type (2018-2029)
4.3 Global Breast Biopsy Solution Price by Type (2018-2029)
5 Segment by Application
5.1 Global Breast Biopsy Solution Sales by Application (2018-2029)
5.1.1 Global Breast Biopsy Solution Sales by Application (2018-2023)
5.1.2 Global Breast Biopsy Solution Sales by Application (2024-2029)
5.1.3 Global Breast Biopsy Solution Sales Market Share by Application (2018-2029)
5.2 Global Breast Biopsy Solution Revenue by Application (2018-2029)
5.2.1 Global Breast Biopsy Solution Revenue by Application (2018-2023)
5.2.2 Global Breast Biopsy Solution Revenue by Application (2024-2029)
5.2.3 Global Breast Biopsy Solution Revenue Market Share by Application (2018-2029)
5.3 Global Breast Biopsy Solution Price by Application (2018-2029)
6 Key Companies Profiled
6.1 Mammotome
6.1.1 Mammotome Corporation Information
6.1.2 Mammotome Description and Business Overview
6.1.3 Mammotome Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Mammotome Breast Biopsy Solution Product Portfolio
6.1.5 Mammotome Recent Developments/Updates
6.2 Hologic
6.2.1 Hologic Corporation Information
6.2.2 Hologic Description and Business Overview
6.2.3 Hologic Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Hologic Breast Biopsy Solution Product Portfolio
6.2.5 Hologic Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Breast Biopsy Solution Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Qiagen
6.4.1 Qiagen Corporation Information
6.4.2 Qiagen Description and Business Overview
6.4.3 Qiagen Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Qiagen Breast Biopsy Solution Product Portfolio
6.4.5 Qiagen Recent Developments/Updates
6.5 Illumina
6.5.1 Illumina Corporation Information
6.5.2 Illumina Description and Business Overview
6.5.3 Illumina Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Illumina Breast Biopsy Solution Product Portfolio
6.5.5 Illumina Recent Developments/Updates
6.6 GE Healthcare
6.6.1 GE Healthcare Corporation Information
6.6.2 GE Healthcare Description and Business Overview
6.6.3 GE Healthcare Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.6.4 GE Healthcare Breast Biopsy Solution Product Portfolio
6.6.5 GE Healthcare Recent Developments/Updates
6.7 Siemens Healthineers
6.6.1 Siemens Healthineers Corporation Information
6.6.2 Siemens Healthineers Description and Business Overview
6.6.3 Siemens Healthineers Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Siemens Healthineers Breast Biopsy Solution Product Portfolio
6.7.5 Siemens Healthineers Recent Developments/Updates
6.8 Trivitron Healthcare
6.8.1 Trivitron Healthcare Corporation Information
6.8.2 Trivitron Healthcare Description and Business Overview
6.8.3 Trivitron Healthcare Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Trivitron Healthcare Breast Biopsy Solution Product Portfolio
6.8.5 Trivitron Healthcare Recent Developments/Updates
6.9 Stryker
6.9.1 Stryker Corporation Information
6.9.2 Stryker Description and Business Overview
6.9.3 Stryker Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Stryker Breast Biopsy Solution Product Portfolio
6.9.5 Stryker Recent Developments/Updates
6.10 Merit Medical Systems
6.10.1 Merit Medical Systems Corporation Information
6.10.2 Merit Medical Systems Description and Business Overview
6.10.3 Merit Medical Systems Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Merit Medical Systems Breast Biopsy Solution Product Portfolio
6.10.5 Merit Medical Systems Recent Developments/Updates
6.11 IZI Medical
6.11.1 IZI Medical Corporation Information
6.11.2 IZI Medical Breast Biopsy Solution Description and Business Overview
6.11.3 IZI Medical Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.11.4 IZI Medical Breast Biopsy Solution Product Portfolio
6.11.5 IZI Medical Recent Developments/Updates
6.12 INRAD
6.12.1 INRAD Corporation Information
6.12.2 INRAD Breast Biopsy Solution Description and Business Overview
6.12.3 INRAD Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.12.4 INRAD Breast Biopsy Solution Product Portfolio
6.12.5 INRAD Recent Developments/Updates
6.13 Argon Medical
6.13.1 Argon Medical Corporation Information
6.13.2 Argon Medical Breast Biopsy Solution Description and Business Overview
6.13.3 Argon Medical Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Argon Medical Breast Biopsy Solution Product Portfolio
6.13.5 Argon Medical Recent Developments/Updates
6.14 Beekley Medical
6.14.1 Beekley Medical Corporation Information
6.14.2 Beekley Medical Breast Biopsy Solution Description and Business Overview
6.14.3 Beekley Medical Breast Biopsy Solution Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Beekley Medical Breast Biopsy Solution Product Portfolio
6.14.5 Beekley Medical Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Breast Biopsy Solution Industry Chain Analysis
7.2 Breast Biopsy Solution Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Breast Biopsy Solution Production Mode & Process
7.4 Breast Biopsy Solution Sales and Marketing
7.4.1 Breast Biopsy Solution Sales Channels
7.4.2 Breast Biopsy Solution Distributors
7.5 Breast Biopsy Solution Customers
8 Breast Biopsy Solution Market Dynamics
8.1 Breast Biopsy Solution Industry Trends
8.2 Breast Biopsy Solution Market Drivers
8.3 Breast Biopsy Solution Market Challenges
8.4 Breast Biopsy Solution Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
